🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We started our DT VAD program in 2019 and did 10 VAD our first year. We did 32 LVAD implants in 2022. This makes us the highest implanting site in the region as well few of the high volume DT sites in the nation. I am so thankful to our entire team! So many lives saved !

Is intermacs registry still relevant ? I am not aware of any centers implanting XVE, HM2, HW?

Next scenario… how big is too big?… what is BMI cut off?

We implanted our 100 HM3 in little less than 4 years yesterday. thankful to our entire team for helping us get here. I would like to thank everyone outside of deborah for supporting our program. When everyone thought it was impossible , our team made it possible!

we will likely see this as a game changer many year from now. As Dr Uriel speaks of “ smart VADs”… perhaps this brings us one step closer. Congrats to the entire team of researchers .

abcnews.go.com/Health/wireSto… So sad :-(

46 LVAD implants at DHLC this year. Special thanks to our entire team for all their hard work. Looking forward to helping more patients in 2024 with this therapy! Also very thankful to our referring providers for trusting us with their patients .

Amazing talk by Dr. Kulpreet barn on evolving landscape of HFpEF ACP-New Jersey 24 Main takeaways: 🌟SGLT2i: Only GDMT drug in HFpEF with class 2a recommendation. Use them! 🌟Consider screening HFpEF patients for amyloid. #DAPAHFtrial

We are pleased to inform that our DOT-HM3 Trial results in partnership between IKEM and The Brigham Harvard just got online! Our results suggest a safety signal of Apixaban use with the HM3 up to a 6-months time point in stable LVAD patients. ahajournals.org/doi/abs/10.116…

Excellent collaboration with the heart and kidney team ⁦⁦NYU Langone Health⁩ to combine an LVAD implant with xeno kidney giving our patient a chance at life. Thank you to our patient and her family as well as our close collaborator ⁦Kulpreet barn⁩ apnews.com/article/pig-or…

I am happy to announce today that I  have started as Medical Director of Heart Failure of Robert Wood Johnson Barnabas Health (RWJBH) system. I would like to thank the leadership at RWJBH for giving me the honor and privilege to serve this region. My home state of New Jersey!

What a great opportunity to learn from the best!

LVADs should be considered as an option for net prolongation of life in young pts. Aditi Nayak Tom Cascino, MD Vanessa Blumer, MD, FACC Katherine Wood Stavros George Drakos Mark Belkin Ryan J Tedford MD STS Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients annalsthoracicsurgery.org/article/S0003-…

Excellent outcomes in younger pts regardless of sex, race or psychosocial support system with HM3 LVAD - a great equalizer! Shelley Hall Anu Lala-Trindade Anthony Carnicelli, MD FACC Rebecca Cogswell Jennifer Cowger Ezequiel Molina MD, FACS, FACC Jaime Hernandez-Montfort Khue Ton Rachna Kataria, MD Nikhil Narang, MD Palak Shah

Admit it - you had so much fun last year that you cannot wait for #THT2025! So roll up your sleeves abstract deadline is Dec 13, 2024. Anu Lala-Trindade Nir Uriel, MD MSc Navin Kapur Rachna Kataria, MD Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Jaime Hernandez-Montfort Ryan J Tedford MD Mark Belkin Vanessa Blumer, MD, FACC Anthony Carnicelli, MD FACC

maybeadoctor Ahmed Bennis Muthu Vaduganathan Javed Butler SCD ⬇️ in HFrEF RCTs where GDMT mandated by trial protocol In clinical practice, SCD, progressive HF☠️, and all-cause ☠️ all ⬆️ since massive gaps in use and dosing in GDMT + rising HF incidence (w/o age adjustment) Want to save 100,000 lives a year? Apply GDMT by protocol

🧵Substrate-based vs. clinical VT ablation?! In ischemic VT, should we pursue substrate mapping (sinus) vs. entrainment mapping (in VT) as ablation strategy? VT recurrence at 12 months: 👉Substrate-based ablation 15% 👉 Clinical ablation 48% VISTA Trial ⬇️

Why go to #THT2025 next week? Because Joann Lindenfeld will be there! As will be Anu Lala-Trindade Nir Uriel, MD MSc Navin Kapur Ryan J Tedford MD Marat Fudim Marta Leon Jennifer Cowger Ezequiel Molina MD, FACS, FACC Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Anthony Carnicelli, MD FACC Gavin Hickey Stavros George Drakos and the one and only Dan Burkhoff MD PhD